Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction.
Wien Klin Wochenschr
; 128(11-12): 450-7, 2016 Jun.
Article
em En
| MEDLINE
| ID: mdl-27278134
ABSTRACT
The protective effect of dual antiplatelet therapy (DAPT) following acute coronary syndrome is undisputed, but its duration is subject of debate. Several studies show that prolonged therapy provides a clinical benefit in patients following acute coronary syndrome. The aim of this position paper authored by Austrian experts is to outline the current evidence and provide an overview of recent studies. It is also intended to serve as a practical guide to identify those patients who may benefit from prolonged DAPT.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Inibidores da Agregação Plaquetária
/
Aspirina
/
Guias de Prática Clínica como Assunto
/
Prevenção Secundária
/
Antagonistas do Receptor Purinérgico P2Y
/
Infarto do Miocárdio
Tipo de estudo:
Guideline
/
Prognostic_studies
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
En
Revista:
Wien Klin Wochenschr
Ano de publicação:
2016
Tipo de documento:
Article
País de afiliação:
Áustria